| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/08/1995 | WO1995015338A1 Chaperonin 10 |
| 06/08/1995 | WO1995015337A1 Alkaline gland fluid proteins and methods of enhancing and inhibiting sperm motility |
| 06/08/1995 | WO1995015334A1 cDNA PROBE FOR BREAST CANCER DIAGNOSIS AND TREATMENT |
| 06/08/1995 | WO1995015331A1 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
| 06/08/1995 | WO1995015180A1 Antibodies that mimic actions of neurotrophins |
| 06/08/1995 | WO1995015175A1 Galectin-8 and galectin-8-like proteins and dna molecules coding therefor |
| 06/08/1995 | WO1995015171A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN |
| 06/08/1995 | WO1995015084A1 Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |
| 06/08/1995 | WO1995011309A3 A novel nuclear mitotic phosphoprotein: mitosin |
| 06/08/1995 | WO1995007708A3 Therapeutic use of the retinoblastoma susceptibility gene product |
| 06/08/1995 | WO1995002054A3 Platelet glycoprotein v gene and uses |
| 06/08/1995 | DE4424761C1 Expression cassette for continuous, stable prodn. of ribozyme |
| 06/08/1995 | DE4341479A1 Antiviral therapy using metallo:thioneine and apo:thioneine |
| 06/08/1995 | DE4341476A1 Compsn. for studying and modulating cellular changes |
| 06/08/1995 | DE4341471A1 New small peptide(s) that inhibit tumour necrosis factor |
| 06/08/1995 | CA2177991A1 A 46 kd human milk fat globule antigen |
| 06/08/1995 | CA2177957A1 Specific fusion nucleic acids and proteins present in human t(2;5) lymphoma, methods of detection and uses thereof |
| 06/08/1995 | CA2177953A1 Plant arabinogalactan protein (agp) genes |
| 06/08/1995 | CA2177816A1 Rna polymerase transcription factor |
| 06/08/1995 | CA2177699A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 06/08/1995 | CA2177584A1 Antibody against carcinoembryonic antigen (cea) |
| 06/08/1995 | CA2177252A1 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer |
| 06/08/1995 | CA2174972A1 Binding structures directed against the ca55.1 antigen |
| 06/07/1995 | EP0656419A1 Method of highly purifying human serum albumin |
| 06/07/1995 | EP0656366A1 Iron-lactoferrin combination and process for producing the same |
| 06/07/1995 | EP0656215A1 Glycosaminoglycan-synthetic polymer conjugates |
| 06/07/1995 | EP0656214A1 Clear, chemically-modified collagensynthetic polymer conjugates for ophthalmic applications |
| 06/07/1995 | EP0656121A1 Method for diagnosing and monitoring sepsis |
| 06/07/1995 | EP0656117A1 A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes gp 130 |
| 06/07/1995 | EP0656114A1 Method of determining metastatic potential of tumor cells |
| 06/07/1995 | EP0656069A1 Inhibitors of cell proliferation, their preparation and use |
| 06/07/1995 | EP0656067A1 Screening methods for immunosuppressive agents |
| 06/07/1995 | EP0656063A1 Nucleotide sequences coding for cryptosporidium proteins, polypeptides coded by said sequences and kits for the use thereof |
| 06/07/1995 | EP0656062A1 Dorsal tissue affecting factor and compositions |
| 06/07/1995 | EP0656061A1 Novel glycoforms of soluble complement receptor 1 |
| 06/07/1995 | EP0656060A1 Androgen regulation with dna sequences of rat probasin gene |
| 06/07/1995 | EP0656059A1 Purified chitinases and use thereof |
| 06/07/1995 | EP0656014A1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
| 06/07/1995 | EP0656013A1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 06/07/1995 | EP0656012A1 T cell epitopes of ryegrass pollen allergen |
| 06/07/1995 | EP0656011A1 Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues |
| 06/07/1995 | EP0656010A1 New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods |
| 06/07/1995 | EP0656007A1 Opioid receptor genes |
| 06/07/1995 | EP0655926A1 New tumor diagnosing or therapeutical probe |
| 06/07/1995 | EP0655888A1 Production of human hemoglobin in transgenic pigs |
| 06/07/1995 | EP0603312A4 Novel gaba a? receptor with steroid binding sites. |
| 06/07/1995 | EP0598034A4 Production of peptide amides. |
| 06/07/1995 | EP0578754B1 TrpR MUTATIONS EFFECTIVE IN THE EXPRESSION OF SMALL PROTEINS AND PEPTIDES |
| 06/07/1995 | EP0465652B1 Antibody against heavy chain of smooth muscle myosin |
| 06/07/1995 | EP0462277B1 Glycoprotein of human origin, physiologically active factor comprising the same, and pharmaceutical preparation containing the same as active ingredient |
| 06/07/1995 | EP0454783B1 Site specific in-vivo activation of therapeutic drugs |
| 06/07/1995 | EP0445128B1 Proteins for fusing the sub-unit b of the choleraic toxin and heterologous antigen, and nucleic acids encoding them |
| 06/07/1995 | EP0383808B1 A gene coding for glucuronide permease |
| 06/07/1995 | EP0330655B1 Method for introduction of disease and pest resistance into plants and novel genes incorporated into plants which code therefor |
| 06/07/1995 | CN1028760C Process for preparing sequence of antidirection direction, antimessenger RNA oligonuclectides of alpha TNF |
| 06/06/1995 | US5422428 Immunization against babesiosis using purified surface antigens of Babesia bigemina and similar immunogens |
| 06/06/1995 | US5422427 Pneumococcal fimbrial protein A |
| 06/06/1995 | US5422426 Solid phase synthesis of oligopeptides for testing as ligands for enzymes and cellular receptors; controlling the concentration and ratios |
| 06/06/1995 | US5422425 For treating diseases associated with elevated levels of the mature hormones: sepsis and autoimmune diseases |
| 06/06/1995 | US5422424 Antibiotic cryptdin peptides and methods of their use |
| 06/06/1995 | US5422341 Motilin-like polypeptides with gastrointestinal motor stimulating activity |
| 06/06/1995 | US5422339 Peptides having insulin autoantibody but not insulin receptor binding capacity |
| 06/06/1995 | US5422284 Method of performing affinity separation using immobilized flocculating agent on chromatographic support |
| 06/06/1995 | US5422282 Methods for detecting autoimmune sensorineural hearing loss |
| 06/06/1995 | US5422279 Lipid fractionation |
| 06/06/1995 | US5422274 Internal deletion mutants of soluble T4(CD4) |
| 06/06/1995 | US5422266 Recombinant DNA vectors capable of expressing apoaequorin |
| 06/06/1995 | US5422265 Provides nucleotide sequence encoding mammalian dopamine receptor having drug dissociation properties of the human dopamine receptor d4 |
| 06/06/1995 | US5422264 Harvesting protein medium secreted by rat bladder carcinoma cells, then culturing epithelial cells in medium |
| 06/06/1995 | US5422263 DNA encoding the Trichinella spirals 53kD excretory/secretory antigen for use as immunodiagnostic reagents |
| 06/06/1995 | US5422260 An isolated protein coagulants for blood clotting; genetic engineering, culture product |
| 06/06/1995 | US5422259 Culturing plants in induction medium containing 6-benzyl aminopurine |
| 06/06/1995 | US5422254 Purified DNA sequence which can be used as genetic vector |
| 06/06/1995 | US5422253 Reproducing a single strands nucleic acid, annealing one end, splitting at target position with a culture product polymerase |
| 06/06/1995 | US5422250 Including in the culture medium a sulfated polysaccharide |
| 06/06/1995 | US5422249 Process for the manufacture of thrombin inhibitors |
| 06/06/1995 | US5422248 Clones having nucleotide sequence from human genes which code amino acid sequences and are active in binding to membranes, solids or whole cells |
| 06/06/1995 | US5422245 Plasminogen activator inhibitor monoclonal antibodies, hybridomas, monoclonal antibody production and use of the antibodies for assay of the inhibitors |
| 06/06/1995 | US5422244 Detection of brain α1-antichymotrypsin |
| 06/06/1995 | US5422239 Sensitivity; purification of vital antigens |
| 06/06/1995 | US5422110 Enhanced immunogenicity using leukotoxin chimeras |
| 06/06/1995 | US5422105 Use of recombinant colony stimulating factor 1 |
| 06/06/1995 | US5422104 TNF-muteins |
| 06/06/1995 | US5422094 19 F labelled antibodies and fragments thereof as NMR imaging and spectroscopy agents |
| 06/06/1995 | US5422090 Human PAI-2 |
| 06/06/1995 | US5421839 Fermentatiion of aspergillus giganteus |
| 06/06/1995 | CA1335802C O-glycosylated igf-1 |
| 06/06/1995 | CA1335800C Synovial phospholipases |
| 06/06/1995 | CA1335797C Differential antigen, nda3, associated with the receptor for b cell growth factor |
| 06/06/1995 | CA1335790C Influenza vaccine |
| 06/06/1995 | CA1335765C Whey protein fractions |
| 06/03/1995 | CA2110772A1 Ltp2 promoter having aleurone-specific activity |
| 06/01/1995 | WO1995014930A1 Kinase receptor activation assay |
| 06/01/1995 | WO1995014791A1 Design of drugs involving receptor-ligand-dna interactions |
| 06/01/1995 | WO1995014787A1 Peptide inhibitors of selecting binding |
| 06/01/1995 | WO1995014785A1 Composition for the in vivo production of therapeutic products |
| 06/01/1995 | WO1995014781A2 Methods for diagnosing early lyme disease |
| 06/01/1995 | WO1995014780A2 Human monoclonal antibodies against human cytokines and methods of making and using such antibodies |
| 06/01/1995 | WO1995014778A2 Dna sequence coding for a bmp receptor |
| 06/01/1995 | WO1995014777A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME |